Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical CorpfiledCriticalMitsubishi Chemical Corp
Publication of AU3357589ApublicationCriticalpatent/AU3357589A/en
Publication of AU611284B2publicationCriticalpatent/AU611284B2/en
Application grantedgrantedCritical
Publication of AU611284CpublicationCriticalpatent/AU611284C/en
Assigned to MITSUBISHI CHEMICAL CORPORATIONreassignmentMITSUBISHI CHEMICAL CORPORATIONRequest to Amend Deed and RegisterAssignors: MITSUBISHI KASEI CORPORATION
AU33575/89A1988-03-311989-03-316-substituted acyclicpyrimidine nucleoside derivatives and antiviral agents containing same as active ingredients
CeasedAU611284C
(en)